- Home
- ANTX vs COCH Comparison
ANTX vs COCH Comparison
Compare ANTX & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- COCH
- Stock Information
- Founded
- ANTX 2017
- COCH 1995
- Country
- ANTX United States
- COCH United States
- Employees
- ANTX N/A
- COCH N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- COCH Blank Checks
- Sector
- ANTX Health Care
- COCH Finance
- Exchange
- ANTX Nasdaq
- COCH Nasdaq
- Market Cap
- ANTX 63.5M
- COCH 64.4M
- IPO Year
- ANTX 2022
- COCH N/A
- Fundamental
- Price
- ANTX $1.07
- COCH $3.31
- Analyst Decision
- ANTX Buy
- COCH Strong Buy
- Analyst Count
- ANTX 4
- COCH 3
- Target Price
- ANTX $2.50
- COCH $7.38
- AVG Volume (30 Days)
- ANTX 204.5K
- COCH 38.5K
- Earning Date
- ANTX 11-07-2024
- COCH 11-15-2024
- Dividend Yield
- ANTX N/A
- COCH N/A
- EPS Growth
- ANTX N/A
- COCH N/A
- EPS
- ANTX N/A
- COCH N/A
- Revenue
- ANTX N/A
- COCH $302,000.00
- Revenue This Year
- ANTX N/A
- COCH N/A
- Revenue Next Year
- ANTX N/A
- COCH $17.09
- P/E Ratio
- ANTX N/A
- COCH N/A
- Revenue Growth
- ANTX N/A
- COCH 38.53
- 52 Week Low
- ANTX $0.87
- COCH $0.75
- 52 Week High
- ANTX $22.22
- COCH $11.46
- Technical
- Relative Strength Index (RSI)
- ANTX 39.40
- COCH 54.00
- Support Level
- ANTX $1.03
- COCH $2.63
- Resistance Level
- ANTX $1.09
- COCH $3.31
- Average True Range (ATR)
- ANTX 0.04
- COCH 0.34
- MACD
- ANTX 0.03
- COCH -0.06
- Stochastic Oscillator
- ANTX 66.67
- COCH 49.93
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.